Project Grant DP2NS131787
- This Project Grant award from the National Science Foundation's Engineering program (CFDA 47.041) provides $434,716 to the University of Oklahoma Health Sciences Center to develop a set of optical tools for capturing and interpreting high-speed recordings of neural activity across the entire zebrafish brain. The key objectives are to create fluorescent voltage sensors, optical microscopes, and signal processing algorithms that can simultaneously monitor millisecond-scale bursts of neural...
- The National Science Foundation (NSF) awarded a $300,000 Project Grant under its Biological Sciences program (CFDA 47.074) to the Georgia TECH Research Corporation for the "TOOLS4CELLS: EAGER: A MOLECULAR PURSUIT FOR THE ENGRAM: MICROFLUIDIC TEMPORAL TRANSCRIPTOMICS FOR SINGLE CELL LEARNING" project. This 2-year effort aims to develop innovative microfluidic tools and workflows to investigate the role of non-coding RNA in learning and memory storage in single-celled organisms. Key...
- This Project Grant award of $194,375 from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) supports the University of Wisconsin-Madison in developing robust genome editing tools for generating floxed alleles and editing amino acid changes in the zebrafish model system. The key objectives are to establish a synthetic exon-mediated integration approach to reliably add LoxP sites to target genes, enabling conditional knockout of genes in specific cell...
- The National Institutes of Health (NIH) Office of the Director awarded a $1,345,424 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the Regents of the University of Michigan. The grant, effective September 10, 2024 through September 9, 2027, aims to develop a novel genetically encoded "protein ticker tape" system that enables long-term, brain-wide recording of single-cell physiology in live mice without external interfacing. The technology will leverage...
- This $1,737,000 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports the development of innovative single-cell genomics technologies for joint analysis of regulatory dynamics and transcriptional states. Key objectives include: Developing multiomics tools to measure rates of epigenomic changes (DNA methylation, demethylation, oxidative damage, DNA repair) and relate these to...
- This $3.21 million cooperative agreement from the National Institutes of Health's National Institute of Neurological Disorders and Stroke will fund research at the California Institute of Technology to develop whole-brain functional imaging and analysis tools to study sleep regulation in zebrafish. Over a three-year period from May 2022 to April 2025, the awardee will use two-photon selective plane illumination microscopy to record neuronal activity with single-cell resolution during natural and...
- This $1,761,170 project grant from the National Institute of Neurological Disorders and Stroke will support research into feedback and feedforward gating of sensory signaling through timing in the thalamocortical loop. The grantee, Georgia Tech Research Corporation, will utilize optogenetic and electrophysiological techniques to precisely measure and manipulate elements of the thalamic-cortical circuit in the whisker somatosensory pathway of awake mice. Specifically, the research aims to...
- This Project Grant award, valued at $481,250.00 and provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to develop a synthetic biological system to manipulate subcellular RNAs and proteins in growth cones or synapses of subtype- and context-specific neurons. The goal is to enable unique forms of subcellular functional investigation in subtype- and...
- This $3.63 million Project Grant from the Department of Health and Human Services National Institutes of Health Office of the Director, under the Trans-NIH Research Support program (CFDA 93.310), will fund research at Duke University from August 2022 through July 2025 to develop predictive dynamic models of the functional connectivity underlying visually guided behavior in zebrafish. Using integrated optical imaging, optogenetic manipulation, and recurrent neural network techniques, the...
- The National Institutes of Health (NIH) Office of the Director awarded a $1,271,280 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the Allen Institute in Seattle, WA. The award, spanning September 2024 to September 2027, aims to develop two "exa-scale" (extremely high-throughput) tissue readout methods to transform the study of the brain. The first method will enable highly multiplexed molecular mapping of individual proteins across entire brains at the...
GENOMIC TOOLS FOR MASSIVELY PARALLEL RECORDING OF SIGNALING ACTIVITY AT CELLULAR RESOLUTION IN A BRAIN-WIDE MANNER - PROJECT SUMMARY/ABSTRACT SIGNALING PATHWAYS HAVE BEEN IMPLICATED IN A MYRIAD OF FUNCTIONS INCLUDING MEDIATING CELL FATE DECISIONS, PROLIFERATION, MIGRATION, AND SPATIAL PATTERNING, AMONG OTHER ROLES. TRADITIONALLY, THESE HAVE BEEN STUDIED IN SPECIFIC CELL TYPES, AT A LIMITED NUMBER OF TIMEPOINTS, AND IN SMALL NUMBERS OF CELLS. THIS PRESENTS THREE LIMITATIONS: 1) OUR UNDERSTANDING OF THESE PATHWAYS HAS RELIED ON "BULK ANALYSIS" OF CELL POPULATIONS, WHICH DILUTES THE SIGNALING EFFECTS OF INDIVIDUAL CELLS. 2) LIVE IMAGING TECHNIQUES PRESERVE CELLULAR RESOLUTION BUT LACK THE SCALABILITY TO EXTEND TO WHOLE TISSUES OR ORGANS. 3) MEASUREMENTS AT ONE OR TWO TIMEPOINTS DO NOT CAPTURE THE CHANGING ROLES OF THESE PATHWAYS AT VARIOUS DEVELOPMENTAL STAGES. THUS, WE NEED TO SHIFT FROM SMALL-SCALE "LOCAL" SNAPSHOTS OF SIGNALING ACTIVITIES TO LARGE-SCALE "GLOBAL" SNAPSHOTS. HERE I DESCRIBE A NOVEL TECHNOLOGY THAT USES CRISPR/CAS TOOLS TO RECORD SIGNALING INPUTS IN EACH CELL'S GENOME AND READS THESE SIGNALS AT HIGH THROUGHPUT WITH SINGLE-CELL RNA SEQUENCING (SCRNA-SEQ). AS A PROOF-OF-CONCEPT, I WILL APPLY THIS TOOL TO INVESTIGATE SIGNALING EVENTS IN THE ZEBRAFISH BRAIN. SEVERAL CRITICAL SIGNALING PATHWAYS HAVE BEEN IDENTIFIED THAT INFLUENCE NEURAL PROGENITOR FATES AND REGULATE SPATIAL PATTERNING OF BRAIN REGIONS. IN THIS STUDY, I FOCUS ON THE NOTCH AND FGF SIGNALING PATHWAYS TO TEST AND VALIDATE THE TECHNOLOGY. THE NOTCH PATHWAY IS AN IMPORTANT MECHANISM THAT MAINTAINS THE BALANCE BETWEEN NEURAL PROGENITOR CELL PROLIFERATION AND DIFFERENTIATION INTO NEURONAL CELL TYPES. FGF SIGNALING HAS MULTIPLE FUNCTIONS IN THE BRAIN INCLUDING FOREBRAIN DEVELOPMENT, SPATIAL PATTERNING AND MODULATING LEFT-RIGHT ASYMMETRY. THE FIRST PART OF THE PROPOSAL DESCRIBES TOOLS TO RECORD SIGNALING ACTIVITY IN THE ZEBRAFISH. IT HAS 5 CORE COMPONENTS: 1) IT USES 3 CAS ORTHOLOGOUS PROTEINS TO INDEPENDENTLY RECORD SIGNALS. 2) IT HAS TEMPORAL INDUCIBILITY OF CAS ACTIVATION. 3) IT ENABLES CONTINUOUS SIGNAL RECORDING AT MULTIPLE TIMEPOINTS. 4) IT FACILITATES RECORDING OF MULTIPLE SIGNALING INPUTS. 5) IT CAN BE SCALED TO WHOLE TISSUES AND ORGANS AND PRESERVES THE RESOLUTION OF SINGLE CELLS. IN THE SECOND PART, I DESCRIBE HOW THE TECHNOLOGY WILL PROVIDE NEW BIOLOGICAL INSIGHTS INTO NOTCH AND FGF SIGNALING. I WILL INVESTIGATE 1) WHETHER NOTCH SIGNALING IN PROGENITORS CORRELATES WITH WHICH TYPES OF NEURONS THE PROGENITORS DIFFERENTIATE INTO; 2) WHETHER NOTCH-MEDIATED ASYMMETRIC DIVISIONS REDUCED THE CELL HETEROGENEITY WITHIN A PROGENITOR NICHE; 3) HOW AND WHEN THE ACTIVITIES OF NOTCH AND FGF INTERSECT TO REGULATE NEUROGENESIS. THE COMBINATION OF CRISPR/CAS-MEDIATED SIGNAL BARCODING AND SCRNA-SEQ PROVIDES A POWERFUL PLATFORM FOR RAPID, SCALABLE AND HIGH-RESOLUTION INVESTIGATION OF SIGNALING ACTIVITY DURING DEVELOPMENT. I ENVISION THAT THIS TECHNOLOGY WILL PROVIDE A FRAMEWORK FOR INNOVATION IN TISSUE ENGINEERING, MODELING DISEASE AND CANCER, AND STUDYING ADULT REGENERATION.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $975.0k | 8/14/25 | ||
| Not listed | $1.5m | 9/21/22 | ||
| Not listed | $1.5m | 9/21/22 |